A New Combo Treatment for Thyroid Cancer
The US Food and Drug Administration (FDA) has approved two medications to treat certain types of thyroid cancer.
Cancer Meds in 2015: A Year in Review
This year was a big one for cancer treatment.
Some Growths Do No Harm
Panic may be the first response for some patients who discover they have a growth. Many growths in the thyroid gland, however, don't go on to cause harm.
FDA Approves Lenvima for a Type of Thyroid Cancer
The U.S. Food and Drug Administration today granted approval to Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive iodine therapy (radioactive iodine refractory disease).
Cancer Screening May Benefit Diabetes Patients
Diabetes patients may need to take extra precautions to lower their risk for cancer or catch it early.
Renal and Thyroid Cancer Increased in US Kids and Teens
Childhood cancer continues to be a leading cause of death among children and teens in the US every year. But rates of two cancers in particular — renal and thyroid — may be rising more than others.
Thyroid Cancer on the Rise in Pennsylvania
Thyroid cancer rates are increasing in the US. But one state may be contributing to the rising rate more than the others.
FDA Approves Nexavar for Advanced Thyroid Cancer
Thankfully, m ost thyroid cancers are treatable. However, when thyroid cancer comes back after treatment or spreads to other areas of the body, the disease is harder to treat.
FDA Approves Nexavar to Treat Type of Thyroid Cancer
The U.S. Food and Drug Administration today expanded the approved uses of Nexavar (sorafenib) to treat late-stage (metastatic) differentiated thyroid cancer.
Surgeons' Ultrasound Saw More Before Cancer Surgery
Once cancer is diagnosed, imaging tests are usually performed to see if the cancer has spread. Medical imaging specialists (radiologists) usually perform these tests, but that shouldn’t always be the case, according to a new review.